IntroductionThe cardiovascular benefits of multiple antihyperglycemic drugs as add-on therapies to metformin in the real-practice are unclear. This study aimed to directly compare major adverse cardiovascular events (CVE) associated with these multiple drugs. MethodsAn emulation of a target trial was conducted using a retrospective-cohort data of type 2 diabetes mellitus (T2DM) prescr... https://ashleyshomestores.shop/product-category/wine-cellar/